VPRBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.698800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.250800E-01
Normal-vs-Stage2
4.763400E-01
Normal-vs-Stage3
1.537640E-01
Normal-vs-Stage4
4.686200E-01
Stage1-vs-Stage2
5.270600E-01
Stage1-vs-Stage3
9.561200E-03
Stage1-vs-Stage4
2.114600E-01
Stage2-vs-Stage3
1.79989999999908E-05
Stage2-vs-Stage4
1.598300E-02
Stage3-vs-Stage4
4.881900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.803000E-01
Normal-vs-AfricanAmerican
8.853000E-01
Normal-vs-Asian
1.877570E-01
Caucasian-vs-AfricanAmerican
4.966800E-01
Caucasian-vs-Asian
1.730820E-01
AfricanAmerican-vs-Asian
1.815020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.804800E-01
Normal-vs-Female
4.711000E-01
Male-vs-Female
8.991600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.879800E-01
Normal-vs-Age(41-60Yrs)
7.009800E-01
Normal-vs-Age(61-80Yrs)
4.173000E-01
Normal-vs-Age(81-100Yrs)
2.615600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.686000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.158000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.629800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.143810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.103800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.951400E-01
Normal-vs-Daily Drinker
3.460000E-01
Normal-vs-Weekly Drinker
3.535600E-01
Normal-vs-Occasional Drinker
8.404200E-01
Normal-vs-Social Drinker
6.311000E-01
Non Drinker-vs-Daily Drinker
9.697600E-01
Non Drinker-vs-Weekly Drinker
9.974000E-01
Non Drinker-vs-Occasional Drinker
1.351440E-01
Non Drinker-vs-Social Drinker
3.318200E-01
Daily Drinker-vs-Weekly Drinker
9.783000E-01
Daily Drinker-vs-Occasional Drinker
1.781570E-01
Daily Drinker-vs-Social Drinker
3.746800E-01
Weekly Drinker-vs-Occasional Drinker
2.353600E-01
Weekly Drinker-vs-Social Drinker
4.235400E-01
Occasional Drinker-vs-Social Drinker
6.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.016230E-01
Normal-vs-Grade 2
2.685500E-02
Normal-vs-Grade 3
1.744190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.357800E-01
Grade 1-vs-Grade 3
1.385960E-01
Grade 1-vs-Grade 4
1.016230E-01
Grade 2-vs-Grade 3
1.747630E-01
Grade 2-vs-Grade 4
2.685500E-02
Grade 3-vs-Grade 4
1.744190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.543600E-01
Normal-vs-NonDiabetic
3.056600E-01
Diabetic-vs-NonDiabetic
8.517400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.633200E-01
Normal-vs-NoPancreatitis
3.927000E-01
Pancreatitis-vs-NoPancreatitis
7.938600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.840800E-01
Normal-vs-N1
4.601200E-01
N0-vs-N1
6.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.784800E-01
Normal-vs-TP53-NonMutant
7.095400E-01
TP53-Mutant-vs-TP53-NonMutant
7.179800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
